Human colorectal cancer cetuximab drug-resistant cell line and application thereof
A cetuximab, colorectal cancer technology, applied in the field of biomedicine, can solve the problem of lack of cetuximab-resistant colorectal cancer cell lines, etc., and achieve high scientific research and production application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] 1. Induction and establishment of human colorectal cancer cetuximab drug-resistant cell line NCI-H508 / C225
[0024] ① NCI-H508 cells were recovered and placed in RPMI-1640 medium containing 10% fetal bovine serum, at 37°C, 5% CO 2 Cultured in an incubator; in order to find the most suitable stimulating concentration of cetuximab, the NCI-H508 cells in the logarithmic growth phase were planted in 96-well culture dishes, and 0.1 μg / ml, 0.5 μg / ml, 1 μg / ml, 5μg / ml, 10μg / ml, 50μg / ml, 100μg / L cetuximab, after 72 hours, the cell viability was detected by the CCK-8 method, and the cell growth inhibition rate was calculated to obtain cetuximab The half inhibitory concentration (IC50) to NCI-H508 cell line.
[0025] ②NCI-H508 cells were stimulated for a long time with the IC50 value detected above at about 10 μg / ml, and after each stimulation for 72 hours, they were replaced with RPMI 1640 complete medium without cetuximab and cultured for 96 hours. After NCI-H508 cells can gr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com